Cargando…

Safety and efficacy of atezolizumab in the treatment of cancers: a systematic review and pooled-analysis

PURPOSE: Immune checkpoint inhibitors have developed rapidly and have demonstrated antitumor activity in various cancers. To evaluate the safety and efficacy of atezolizumab in treating cancers, we conducted this meta-analysis. METHODS: Embase, PubMed, MEDLINE, the Central Register of Controlled Tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tie, Yan, Yang, Hui, Zhao, Rui, Zheng, Heng, Yang, Daoke, Zhao, Jingyi, Liu, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366347/ https://www.ncbi.nlm.nih.gov/pubmed/30787594 http://dx.doi.org/10.2147/DDDT.S188893

Ejemplares similares

Evaluation of atezolizumab immunogenicity: Efficacy and safety (Part 2)
por: Peters, Solange, et al.
Publicado: (2021)

Efficacy and safety of atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma in the real world: a single-arm meta-analysis
por: Gao, Xiaoqiang, et al.
Publicado: (2023)

Clinical efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
por: Du, Sihao, et al.
Publicado: (2023)

Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma
por: Zanuso, Valentina, et al.
Publicado: (2023)

Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
por: Ahmed, Faiza, et al.
Publicado: (2021)

Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma
por: Su, Chung‐Wei, et al.
Publicado: (2022)

Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
por: Xin, Yujing, et al.
Publicado: (2022)

Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
por: Yano, Shigeki, et al.
Publicado: (2023)

Combined atezolizumab and nab-paclitaxel in the treatment of triple negative breast cancer: a meta-analysis on their efficacy and safety
por: Sharmni Vishnu, K., et al.
Publicado: (2022)

Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis
por: Kulkarni, Anand V., et al.
Publicado: (2023)

Efficacy and safety of leadless pacemaker: A systematic review, pooled analysis and meta-analysis
por: Darlington, Daniel, et al.
Publicado: (2021)

Safety and efficacy of multiband mucosectomy for Barrett’s esophagus: a systematic review with pooled analysis
por: Spadaccini, Marco, et al.
Publicado: (2021)

Electrolyte Abnormalities Associated With the Use of Atezolizumab – A Systematic Review
por: Rafae, Abdul, et al.
Publicado: (2022)

Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis
por: Tada, Toshifumi, et al.
Publicado: (2022)

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Efficacy and safety of selinexor in the treatment of AML: A protocol for systematic review and meta-analysis
por: Yu, Liming, et al.
Publicado: (2021)

Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers
por: Himmelsbach, Vera, et al.
Publicado: (2022)

The Traditional Chinese Medicine and Relevant Treatment for the Efficacy and Safety of Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Shi, Zhao-feng, et al.
Publicado: (2017)

Efficacy and Treatment Strategies in Advanced Cancers with Liver Metastasis Receiving Atezolizumab Therapy
por: Yin, Wen-Jing, et al.
Publicado: (2021)

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Lambert, Nicolas, et al.
Publicado: (2022)

The Efficacy and Safety of Revefenacin for the Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review
por: Zhang, Jiaxing, et al.
Publicado: (2021)

Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol
por: Wang, Kang, et al.
Publicado: (2022)

Efficacy and safety of durvalumab + chemotherapy vs. atezolizumab + chemotherapy in the treatment of small‑cell lung cancer: a retrospective comparative cohort study
por: Zou, Yuxia, et al.
Publicado: (2023)

Pan‐cancer population pharmacokinetics and exposure‐safety and ‐efficacy analyses of atezolizumab in patients with high tumor mutational burden
por: Shemesh, Colby S., et al.
Publicado: (2020)

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study
por: Joerg, Vincent, et al.
Publicado: (2023)

Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy, safety and place in therapy
por: Jean, Fanny, et al.
Publicado: (2017)

Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study
por: Sherman, E., et al.
Publicado: (2023)

The efficacy and safety of pharmacologic thromboprophylaxis following caesarean section: A systematic review and meta-analysis
por: Yang, Rui, et al.
Publicado: (2018)

Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis
por: Wang, Ke, et al.
Publicado: (2023)

The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis
por: Cao, Heng, et al.
Publicado: (2015)

Safety and efficacy of partial hepatectomy for huge (≥10 cm) hepatocellular carcinoma: A systematic review
por: Zhou, Yan-Ming, et al.
Publicado: (2011)

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2022)

Efficacy and Safety of Gabapentin in the Treatment of Chronic Cough: A Systematic Review
por: Shi, Guanglin, et al.
Publicado: (2018)

Dose age affect the efficacy of molecular targeted agents in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis
por: Du, Jing, et al.
Publicado: (2017)

Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
por: Li, Maohua, et al.
Publicado: (2021)

Efficacy and safety of acupuncture for patients with pseudomyopia: A protocol for systematic review and meta-analysis
por: Niu, Ye, et al.
Publicado: (2022)

Safety and Efficacy of Antiviral Drugs for the Treatment of COVID-19: A Systematic Review
por: Nie, Zhenwang, et al.
Publicado: (2022)

Efficacy and safety of colchicine in the treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis
por: Xiong, Hui, et al.
Publicado: (2021)

Efficacy and safety of antimicrobial de-escalation of treatment for sepsis: A protocol for systematic review and meta-analysis
por: Zhu, Hong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_31rulfrrtjrrjscmcppm7tmt24